Medicare Benefit Appears to Slow Spending Growth on Drugs

Federal number crunchers said yesterday that the new Medicare drug benefit appears to be slowing the growth in national spending on prescription medicines because the drug plans are negotiating lower prices with drug companies.
 - 

Christopher Lee

Related Subjects

Centers for Medicare & Medicaid Services

Karen Davis

George W. Bush

John Poisal

AARP

North America

Healthcare Issues

Prescription Drug Costs

Medicine

Health and Fitness

Health and Medical Insurance Carriers

Health Care Plans

Health and Human Services Sector

Healthcare Policy

Political Policy

Politics

Social Policy

Domestic Policy

Prescription Benefits Management

Pharmaceuticals Industry

Pharmaceuticals and Biotechnology Sector

National Economy

Business

Powered by Inform

Related Articles

Judge refuses to halt Caremark deal Boston Globe 2/23/2007 8:01:17 PM

NMHC Names Thomas W. Erickson Chairman of the Board of Directors Investors Business Daily 2/23/2007 7:53:29 PM

Judge delays Caremark vote; wants more details Reuters 2/23/2007 6:13:19 PM

Judge Delays Caremark Vote; Asks for More Details New York Times 2/23/2007 6:02:11 PM

Mail Order Drugs Debated Military.com 2/23/2007 11:54:24 AM

Caremark shares up ahead of judge's ruling (10:11am) Nashville Tennessean 2/23/2007 11:42:37 AM

Osceola moves to counter workers' prescription shock South Bend Tribune 2/23/2007 7:06:09 AM

RCGA: Casteel is hired as VP St. Louis Post-Dispatch 2/23/2007 4:30:25 AM

Local business briefs: Caremark may hear today about CVS deal Nashville Tennessean 2/23/2007 3:01:23 AM

Health Care, Other Small Business Issues On Congressional Agenda; Republican Leaders Outline Proposals Medical News Today 2/23/2007 1:14:17 AM

Powered by Inform